Results 141 to 150 of about 12,104 (196)

T cell exhaustion in poorly immunogenic HCC is partially rescued by checkpoint blockade but suppressed by oncolytic virotherapy. [PDF]

Mol Ther
Sangsuwannukul T, Kendall B, Tonne J, Liseth O, Thompson J, Supimon K, Metko MM, Chen A, Yerovi MPC, Diaz RM, Evgin L, Webb MJ, van Vloten J, Monga SP, Irshad S, McNiven M, Roberts L, Vile RG.   +17 more
europepmc   +1 more source

Insights from veterinary models for advancing oncolytic virotherapy through comparative oncology. [PDF]

Front Mol Biosci
Alkayyal AA.
europepmc   +1 more source

Correction: Single-cell analysis of oncolytic virotherapy in adult T-cell leukemia/lymphoma. [PDF]

J Immunother Cancer
europepmc   +1 more source

A bibliometric analysis of oncolytic virotherapy combined with immunotherapy. [PDF]

Hum Vaccin Immunother
Zhang T, Jiang S, Zhang L, Liu Y, Zheng H, Zhao H, Du S, Xu Y, Lu X.   +8 more
europepmc   +1 more source

Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment. [PDF]

Front Immunol
Jennings VA, Rumbold-Hall R, Migneco G, Barr T, Reilly K, Ingram N, Hilare IS, Heaton S, Alzamel N, Jackson D, Ralph C, Banerjee S, McNeish I, Bell JC, Melcher AA, Ilkow C, Cook GP, Errington-Mais F.   +17 more
europepmc   +1 more source

Effects of virus-induced immunogenic cues on oncolytic virotherapy. [PDF]

Sci Rep
Bhatt DK, Janzen T, Daemen T, Weissing FJ.   +3 more
europepmc   +1 more source

Induction of abscopal effect combining H101 oncolytic virotherapy with tislelizumab in a patient with advanced hepatocellular carcinoma: a case report. [PDF]

Am J Cancer Res
Ou D, Li Y, Wu J, Ou S, Xie F.
europepmc   +1 more source

Single-cell analysis of oncolytic virotherapy in adult T-cell leukemia/lymphoma. [PDF]

J Immunother Cancer
An J, Hu E, Shi Y, Fang Y, Liu N, Liu Q, Wang Q, Wang Y, He W, Wang A, Song Y, Shan J, Zhang J, Zou Y, Cheng H, Kabarriti R, Cai W, Verma A, Sica RA, Deng W, Yin S.   +20 more
europepmc   +1 more source

Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma. [PDF]

Nat Commun
Zhang J, Yang J, Luo J, Wu W, Luo H, Wei W, Lyu H, Wang Y, Yi H, Zhang Y, Fan Z, Lyu H, Kanakaveti VP, Qin B, Yuan P, Yang R, Zhang H, Zuo T, Felsher DW, Lee MH, Li K.   +20 more
europepmc   +1 more source

Blocking Feedback Immunosuppression of Antigen Presentation in Brain Tumor During Oncolytic Virotherapy with oHSV-mshPKR. [PDF]

Mol Cancer Ther
Tsuboi N, Rivera-Caraballo KA, Sahu U, Pacholczyk R, Douglass E, Johnson TS, Wang Q, Kolhe R, Hedrick CC, Munn DH, Hong B.   +10 more
europepmc   +1 more source